TY - STD TI - Boehringer Ingelheim: Summary of Product Characteristics (SPC): Spiriva Respimat 2.5 micrograms solution for inhalation (United Kingdom). Accessed 24th September 2012 [http://www.medicines.org.uk/EMC/history/20134/SPC/Spiriva + Respimat + 2.5 + micrograms + solution + for + inhalation#01/10/2007] UR - http://www.medicines.org.uk/EMC/history/20134/SPC/Spiriva%20+%20Respimat%20+%202.5%20+%20micrograms%20+%20solution%20+%20for%20+%20inhalation#01/10/2007 ID - ref1 ER - TY - JOUR AU - van Noord, J. A. AU - Cornelissen, P. J. AU - Aumann, J. L. AU - Platz, J. AU - Mueller, A. AU - Fogarty, C. PY - 2009 DA - 2009// TI - The efficacy of tiotropium administered via Respimat Soft Mist Inhaler or HandiHaler in COPD patients JO - Respir Med VL - 103 UR - https://doi.org/10.1016/j.rmed.2008.10.002 DO - 10.1016/j.rmed.2008.10.002 ID - van Noord2009 ER - TY - JOUR AU - Ichinose, M. AU - Fujimoto, T. AU - Fukuchi, Y. PY - 2010 DA - 2010// TI - Tiotropium 5microg via Respimat and 18microg via HandiHaler; efficacy and safety in Japanese COPD patients JO - Respir Med VL - 104 UR - https://doi.org/10.1016/j.rmed.2009.11.011 DO - 10.1016/j.rmed.2009.11.011 ID - Ichinose2010 ER - TY - JOUR AU - Bateman, E. D. AU - Tashkin, D. AU - Siafakas, N. AU - Dahl, R. AU - Towse, L. AU - Massey, D. AU - Pavia, D. AU - Zhong, N. S. PY - 2010 DA - 2010// TI - A one-year trial of tiotropium Respimat plus usual therapy in COPD patients JO - Respir Med VL - 104 UR - https://doi.org/10.1016/j.rmed.2010.06.004 DO - 10.1016/j.rmed.2010.06.004 ID - Bateman2010 ER - TY - JOUR AU - Tashkin, D. P. AU - Celli, B. AU - Senn, S. AU - Burkhart, D. AU - Kesten, S. AU - Menjoge, S. AU - Decramer, M. PY - 2008 DA - 2008// TI - A 4-year trial of tiotropium in chronic obstructive pulmonary disease JO - N Engl J Med VL - 359 UR - https://doi.org/10.1056/NEJMoa0805800 DO - 10.1056/NEJMoa0805800 ID - Tashkin2008 ER - TY - STD TI - Boehringer Ingelheim: Tiotropium (SPIRIVA®): Pulmonary Allergy Drug Advisory Meeting -. 2009, Accessed 24th September 2012 [http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM190466.pdf.], November UR - http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM190466.pdf ID - ref6 ER - TY - JOUR AU - Singh, S. AU - Loke, Y. K. AU - Enright, P. L. AU - Furberg, C. D. PY - 2011 DA - 2011// TI - Mortality associated with tiotropium mist inhaler in patients with chronic obstructive pulmonary disease: systematic review and meta-analysis of randomised controlled trials JO - BMJ VL - 342 UR - https://doi.org/10.1136/bmj.d3215 DO - 10.1136/bmj.d3215 ID - Singh2011 ER - TY - JOUR AU - Bateman, E. AU - Singh, D. AU - Smith, D. AU - Disse, B. AU - Towse, L. AU - Massey, D. AU - Blatchford, J. AU - Pavia, D. AU - Hodder, R. PY - 2010 DA - 2010// TI - Efficacy and safety of tiotropium Respimat SMI in COPD in two 1-year randomized studies JO - Int J Chron Obstruct Pulmon Dis VL - 5 ID - Bateman2010 ER - TY - STD TI - Disse B, Metzdorf N, Martin A, Cerasoli F, Leimer I: Mortality associated with tiotropium mist inhaler? A critical appraisal of the authors' selection and use of previously communicated tiotropium Respimat data. Accessed 5th April 2013 [http://www.bmj.com/rapid-response/2011/11/03/mortality-associated-tiotropium-mist-inhaler-critical-appraisal-authors-se] UR - http://www.bmj.com/rapid-response/2011/11/03/mortality-associated-tiotropium-mist-inhaler-critical-appraisal-authors-se ID - ref9 ER - TY - JOUR AU - Dong, Y. H. AU - Lin, H. H. AU - Shau, W. Y. AU - Wu, Y. C. AU - Chang, C. H. AU - Lai, M. S. PY - 2013 DA - 2013// TI - Comparative safety of inhaled medications in patients with chronic obstructive pulmonary disease: systematic review and mixed treatment comparison meta-analysis of randomised controlled trials JO - Thorax VL - 68 UR - https://doi.org/10.1136/thoraxjnl-2012-201926 DO - 10.1136/thoraxjnl-2012-201926 ID - Dong2013 ER - TY - CHAP AU - Karner, C. AU - Chong, J. AU - Poole, P. PY - 2012 DA - 2012// TI - Tiotropium versus placebo for chronic obstructive pulmonary disease BT - Cochrane Database Syst Rev ID - Karner2012 ER - TY - JOUR AU - Loke, Y. K. AU - Singh, S. PY - 2012 DA - 2012// TI - Risks associated with tiotropium in COPD. Overview of the evidence to date JO - Ther Adv in Drug Safe VL - 3 UR - https://doi.org/10.1177/2042098612438388 DO - 10.1177/2042098612438388 ID - Loke2012 ER - TY - STD TI - Boehringer Ingelheim: Tiotropium Respimat Pharmacokinetic Study in COPD. Accessed 20th February 2013 [http://www.clinicaltrials.gov/ct2/show/NCT01222533] UR - http://www.clinicaltrials.gov/ct2/show/NCT01222533 ID - ref13 ER - TY - JOUR AU - Shavelle, R. M. AU - Paculdo, D. R. AU - Kush, S. J. AU - Mannino, D. M. AU - Strauss, D. J. PY - 2009 DA - 2009// TI - Life expectancy and years of life lost in chronic obstructive pulmonary disease: findings from the NHANES III Follow-up Study JO - Int J Chron Obstruct Pulmon Dis VL - 4 UR - https://doi.org/10.2147/COPD.S5237 DO - 10.2147/COPD.S5237 ID - Shavelle2009 ER -